Minor
QUATRO-APL · QTX-2101 · Acute Promyelocytic Leukemia
Trial sites expanded: 28 → 33 locations
Quetzal TherapeuticsPhase 3 NCT07504458 Registry history of NCT07504458 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.
Trial sites expanded: 28 → 33 locations
Quetzal TherapeuticsPhase 3 NCT07504458 Registry history of NCT07504458 on ClinicalTrials.gov (opens the registry)
| Phase 3 | 1 |
Acute Myeloid Leukemia (AML) (1) · Leukemia (1)